Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NGL FINE CHM vs FREDUN PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NGL FINE CHM FREDUN PHARMA NGL FINE CHM/
FREDUN PHARMA
 
P/E (TTM) x 33.7 23.3 144.3% View Chart
P/BV x 5.8 3.8 151.5% View Chart
Dividend Yield % 0.1 0.1 85.8%  

Financials

 NGL FINE CHM   FREDUN PHARMA
EQUITY SHARE DATA
    NGL FINE CHM
Mar-23
FREDUN PHARMA
Mar-23
NGL FINE CHM/
FREDUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,5691,428 179.9%   
Low Rs1,161675 172.1%   
Sales per share (Unadj.) Rs450.0606.3 74.2%  
Earnings per share (Unadj.) Rs33.223.9 139.0%  
Cash flow per share (Unadj.) Rs51.430.1 171.1%  
Dividends per share (Unadj.) Rs1.750.70 250.0%  
Avg Dividend yield %0.10.1 140.9%  
Book value per share (Unadj.) Rs360.1194.4 185.3%  
Shares outstanding (eoy) m6.184.53 136.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.11.7 238.8%   
Avg P/E ratio x56.244.1 127.5%  
P/CF ratio (eoy) x36.335.0 103.6%  
Price / Book Value ratio x5.25.4 95.7%  
Dividend payout %5.32.9 179.7%   
Avg Mkt Cap Rs m11,5234,766 241.8%   
No. of employees `000NANA-   
Total wages/salary Rs m369115 319.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,7812,747 101.2%  
Other income Rs m5518 299.9%   
Total revenues Rs m2,8362,765 102.6%   
Gross profit Rs m350288 121.3%  
Depreciation Rs m11328 402.0%   
Interest Rs m18104 17.7%   
Profit before tax Rs m274175 156.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6967 102.4%   
Profit after tax Rs m205108 189.7%  
Gross profit margin %12.610.5 119.8%  
Effective tax rate %25.138.3 65.6%   
Net profit margin %7.43.9 187.3%  
BALANCE SHEET DATA
Current assets Rs m1,6272,162 75.2%   
Current liabilities Rs m5831,062 54.9%   
Net working cap to sales %37.540.1 93.7%  
Current ratio x2.82.0 137.0%  
Inventory Days Days653 2,007.9%  
Debtors Days Days865459 188.3%  
Net fixed assets Rs m1,244411 303.0%   
Share capital Rs m3145 68.2%   
"Free" reserves Rs m2,195835 262.8%   
Net worth Rs m2,225880 252.8%   
Long term debt Rs m21489 4.2%   
Total assets Rs m2,8712,573 111.6%  
Interest coverage x15.92.7 591.5%   
Debt to equity ratio x00.6 1.7%  
Sales to assets ratio x1.01.1 90.7%   
Return on assets %7.88.2 94.6%  
Return on equity %9.212.3 75.0%  
Return on capital %13.020.3 63.9%  
Exports to sales %74.322.6 329.0%   
Imports to sales %9.90.2 5,180.0%   
Exports (fob) Rs m2,066620 333.1%   
Imports (cif) Rs m2765 5,240.2%   
Fx inflow Rs m2,095620 337.7%   
Fx outflow Rs m3045 5,774.8%   
Net fx Rs m1,790615 291.1%   
CASH FLOW
From Operations Rs m353-144 -244.9%  
From Investments Rs m-270-94 287.3%  
From Financial Activity Rs m-11252 -4.3%  
Net Cashflow Rs m7214 527.1%  

Share Holding

Indian Promoters % 73.1 49.2 148.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 1.6 2.5%  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.9 50.8 53.0%  
Shareholders   16,410 6,837 240.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NGL FINE CHM With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on NGL FINE CHM vs FREDUN PHARMA

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NGL FINE CHM vs FREDUN PHARMA Share Price Performance

Period NGL FINE CHM FREDUN PHARMA S&P BSE HEALTHCARE
1-Day -0.58% -0.69% 1.18%
1-Month 2.94% -15.26% -0.75%
1-Year 77.47% -10.21% 61.82%
3-Year CAGR 9.82% 15.57% 18.16%
5-Year CAGR 35.36% 10.58% 19.79%

* Compound Annual Growth Rate

Here are more details on the NGL FINE CHM share price and the FREDUN PHARMA share price.

Moving on to shareholding structures...

The promoters of NGL FINE CHM hold a 73.1% stake in the company. In case of FREDUN PHARMA the stake stands at 49.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NGL FINE CHM and the shareholding pattern of FREDUN PHARMA.

Finally, a word on dividends...

In the most recent financial year, NGL FINE CHM paid a dividend of Rs 1.8 per share. This amounted to a Dividend Payout ratio of 5.3%.

FREDUN PHARMA paid Rs 0.7, and its dividend payout ratio stood at 2.9%.

You may visit here to review the dividend history of NGL FINE CHM, and the dividend history of FREDUN PHARMA.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.